BNTX icon

BioNTech
BNTX

Overview Fund Activity

263 hedge funds and large institutions have $5B invested in BioNTech in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 75 increasing their positions, 99 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
263
Holders Change
-29
Holders Change %
-9.93%
% of All Funds
4.55%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
24
Increased
75
Reduced
99
Closed
49
Calls
$295M
Puts
$427M
Net Calls
-$132M
Net Calls Change
+$151M

Top Buyers

1
Temasek Holdings
1
Temasek Holdings
Singapore
$591M
2
Artisan Partners
2
Artisan Partners
Wisconsin
$301M
3
Capital World Investors
3
Capital World Investors
California
$219M
4
Flossbach Von Storch
4
Flossbach Von Storch
Germany
$454M
5
SEI Investments
5
SEI Investments
Pennsylvania
$42.4M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$169M
2
Millennium Management
2
Millennium Management
New York
$11.6M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$11.8M
4
Citadel Advisors
4
Citadel Advisors
Florida
$3.18M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VVP
301
Venture Visionary Partners
Ohio
– -$2.83K -19 Closed
IUHSA
302
Itau Unibanco Holding S.A.
Brazil
– -$2K -16 Closed
9 10 11 12
13